StoneX Reiterates Buy Rating on Prenetics (PRE)
StoneX analyst Bill Sutherland reiterated a Buy rating and $40.00 price target on Prenetics (NASDAQ: PRE).The analyst commented, "We reiterate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
